Clinical Trial Update: Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin [Phase 2, Phase 3]

View source ↗

Summary

This entry describes a Phase 2/Phase 3 clinical trial evaluating oral vancomycin for primary prophylaxis of Clostridioides difficile infection, with status not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Vancomycin-resistant Enterococcus Faecium Infection

Drugs mentioned

• vancomycin (oral) (vancomycin)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Clostridioides Difficile, Vancomycin Resistance Enterococcus Faecium | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING